{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:54:55Z","timestamp":1790848495163,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T00:00:00Z","timestamp":1708214400000},"content-version":"am","delay-in-days":262,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005405","name":"Ritsumeikan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012359","name":"Promotion and Mutual Aid Corporation for Private Schools of Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22mk0101214h0002"],"award-info":[{"award-number":["22mk0101214h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K15264"],"award-info":[{"award-number":["21K15264"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.dmpk.2023.100497","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T20:33:20Z","timestamp":1676666000000},"page":"100497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Generation of Caco-2\u00a0cells with predictable metabolism by CYP3A4, UGT1A1 and CES using the PITCh system"],"prefix":"10.1016","volume":"50","author":[{"given":"Naoki","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6567-575X","authenticated-orcid":false,"given":"Ryosuke","family":"Negoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7724-6522","authenticated-orcid":false,"given":"Takuya","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2023.100497_bib1","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1208\/ps020106","article-title":"Targeted prodrug design to optimize drug delivery","volume":"2","author":"Han","year":"2000","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.dmpk.2023.100497_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/molecules13020412","article-title":"Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs","volume":"13","author":"Hosokawa","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.dmpk.2023.100497_bib3","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1124\/dmd.106.009381","article-title":"Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine","volume":"34","author":"Imai","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2023.100497_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105807","article-title":"Hydrolase activities of cynomolgus monkey liver microsomes and recombinant CES1, CES2, and AADAC","volume":"161","author":"Honda","year":"2021","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.dmpk.2023.100497_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1359-6446(04)03354-9","article-title":"Cell culture-based models for intestinal permeability: a critique","volume":"10","author":"Balimane","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.dmpk.2023.100497_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/17425255.4.4.395","article-title":"The Caco-2 cell monolayer: usefulness and limitations","volume":"4","author":"Sun","year":"2008","journal-title":"Expet Opin Drug Metabol Toxicol"},{"key":"10.1016\/j.dmpk.2023.100497_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1472-8206.2007.00550.x","article-title":"Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR","volume":"21","author":"Maubon","year":"2007","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2023.100497_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2005.03.008","article-title":"Validation of the 96 well Caco-2 cell culture model for high throughput permeability assessment of discovery compounds","volume":"297","author":"Marino","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.dmpk.2023.100497_bib9","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1124\/dmd.114.059493","article-title":"Human small intestinal epithelial cells differentiated from adult intestinal stem cells as a novel system for predicting oral drug absorption in humans","volume":"42","author":"Takenaka","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2023.100497_bib10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0090-9556(25)07382-9","article-title":"Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells","volume":"24","author":"Prueksaritanont","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2023.100497_bib11","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1023\/A:1020483911355","article-title":"Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs","volume":"19","author":"Sun","year":"2002","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.dmpk.2023.100497_bib12","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1006\/bbrc.2000.3064","article-title":"Immunochemical identification of UGT isoforms in human small bowel and in caco-2 cell monolayers","volume":"273","author":"Paine","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dmpk.2023.100497_bib13","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1124\/dmd.105.004226","article-title":"Identification of esterases expressed in Caco-2 cells and effects of their hydrolyzing activity in predicting human intestinal absorption","volume":"33","author":"Imai","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2023.100497_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00204-021-03175-0","article-title":"Generation of Caco-2 cells stably expressing CYP3A4\u00b7POR\u00b7UGT1A1 and CYP3A4\u00b7POR\u00b7UGT1A1\u22176 using a PITCh system","volume":"96","author":"Negoro","year":"2022","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.dmpk.2023.100497_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/srep05400","article-title":"Multiplex genome engineering in human cells using all-in-one CRISPR\/Cas9 vector system","volume":"4","author":"Sakuma","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.dmpk.2023.100497_bib16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nprot.2015.140","article-title":"MMEJ-Assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems","volume":"11","author":"Sakuma","year":"2016","journal-title":"Nat Protoc"},{"key":"10.1016\/j.dmpk.2023.100497_bib17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1248\/bpb.b17-00880","article-title":"Development of a caco-2 cell line carrying the human intestine-type CES expression profile as a promising tool for ester-containing drug permeability studies","volume":"41","author":"Ishizaki","year":"2018","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.dmpk.2023.100497_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.dmpk.2016.08.004","article-title":"Development of Caco-2 cells co-expressing CYP3A4 and NADPH-cytochrome P450 reductase using a human artificial chromosome for the prediction of intestinal extraction ratio of CYP3A4 substrates","volume":"32","author":"Takenaka","year":"2017","journal-title":"Drug Metabol Pharmacokinet"},{"key":"10.1016\/j.dmpk.2023.100497_bib19","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1023\/A:1016428304366","article-title":"Development of Caco-2 cells expressing high levels of cDNA-derived cytochrome P4503A4","volume":"13","author":"Crespi","year":"1996","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.dmpk.2023.100497_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91160-z","article-title":"Generation of tetracycline-controllable CYP3A4-expressing Caco-2 cells by the piggyBac transposon system","volume":"11","author":"Ichikawa","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.dmpk.2023.100497_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0165-4608(00)00391-5","article-title":"DNA amplification and chromosomal translocations are accompanied by chromosomal instability: analysis of seven human colon cancer cell lines by comparative genomic hybridization and spectral karyotyping","volume":"126","author":"Tsushimi","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.dmpk.2023.100497_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/gcc.10268","article-title":"Premature chromosome condensation revisited: a novel chemical approach permits efficient cytogenetic analysis of cancers","volume":"38","author":"Bezrookove","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.dmpk.2023.100497_bib23","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.dmpk.2023.100497_bib24","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.tibtech.2020.10.010","article-title":"Next-generation CRISPR technologies and their applications in gene and cell therapy","volume":"39","author":"Zeballos","year":"2021","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.dmpk.2023.100497_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.omtm.2019.11.008","article-title":"Establishment of SLC15A1\/PEPT1-knockout human-induced pluripotent stem cell line for intestinal drug absorption studies","volume":"17","author":"Kawai","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.dmpk.2023.100497_bib26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.dmpk.2020.01.009","article-title":"Establishment of MDR1-knockout human induced pluripotent stem cell line","volume":"35","author":"Negoro","year":"2020","journal-title":"Drug Metabol Pharmacokinet"},{"key":"10.1016\/j.dmpk.2023.100497_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc3179","article-title":"Safe harbours for the integration of new DNA in the human genome","volume":"12","author":"Sadelain","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.dmpk.2023.100497_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejps.2015.07.006","article-title":"Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases","volume":"78","author":"Fukami","year":"2015","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.dmpk.2023.100497_bib29","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1124\/dmd.114.056994","article-title":"Screening of specific inhibitors for human carboxylesterases or arylacetamide deacetylase","volume":"42","author":"Shimizu","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2023.100497_bib30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jcmgh.2019.06.004","article-title":"Generation of human iPSC-derived intestinal epithelial cell monolayers by CDX2 transduction","volume":"8","author":"Takayama","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.dmpk.2023.100497_bib31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.omtm.2021.01.005","article-title":"Vinblastine treatment decreases the undifferentiated cell contamination of human iPSC-derived intestinal epithelial-like cells","volume":"20","author":"Ichikawa","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.dmpk.2023.100497_bib32","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.stemcr.2018.10.019","article-title":"Efficient generation of small intestinal epithelial-like cells from human iPSCs for drug absorption and metabolism studies","volume":"11","author":"Negoro","year":"2018","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.dmpk.2023.100497_bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbrc.2017.03.014","article-title":"Functional analysis of carboxylesterase in human induced pluripotent stem cell-derived enterocytes","volume":"486","author":"Kabeya","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dmpk.2023.100497_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.omtm.2021.05.005","article-title":"Monolayer platform using human biopsy-derived duodenal organoids for pharmaceutical research","volume":"22","author":"Yamashita","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.dmpk.2023.100497_bib35","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.50135","article-title":"Duodenum Intestine-Chip for preclinical drug assessment in a human relevant model","volume":"9","author":"Kasendra","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.dmpk.2023.100497_bib36","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1124\/dmd.118.083246","article-title":"Application of intestinal epithelial cells differentiated from human induced pluripotent stem cells for studies of prodrug hydrolysis and drug absorption in the small intestine","volume":"46","author":"Akazawa","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2023.100497_bib37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003088-199835050-00003","article-title":"Inhibition and induction of cytochrome P450 and the clinical implications","volume":"35","author":"Lin","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dmpk.2023.100497_bib38","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00204-008-0332-8","article-title":"Inhibition and induction of human cytochrome P450 enzymes: current status","volume":"82","author":"Pelkonen","year":"2008","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.dmpk.2023.100497_bib39","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbrc.2016.03.012","article-title":"Modeling of drug-mediated CYP3A4 induction by using human iPS cell-derived enterocyte-like cells","volume":"472","author":"Negoro","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dmpk.2023.100497_bib40","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/01.fpc.0000220561.59972.7a","article-title":"Identification of potential pharmacological and toxicological targets differentiating structural analogs by a combination of transcriptional profiling and promoter analysis in LS-180 and Caco-2 adenocarcinoma cell lines","volume":"16","author":"Hartley","year":"2006","journal-title":"Pharmacogenetics Genom"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436723000095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436723000095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:57:24Z","timestamp":1761163044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436723000095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":40,"alternative-id":["S1347436723000095"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2023.100497","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of Caco-2\u00a0cells with predictable metabolism by CYP3A4, UGT1A1 and CES using the PITCh system","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2023.100497","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100497"}}